INTECH Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.4M	Buy	86,315 +45,837	+113%	+$6.08M	0.11%	157
2025 Q4	$5.74M	Buy	40,478 +5,823	+17%	+$844K	0.05%	324
2025 Q3	$4.86M	Buy	34,655 +6,307	+22%	+$855K	0.04%	387
2025 Q2	$3.56M	Sell	28,348 -7,476	-21%	-$857K	0.03%	470
2025 Q1	$3.96M	Sell	35,824 -82,590	-70%	-$10.5M	0.04%	405
2024 Q4	$16.2M	Buy	118,414 +15,819	+15%	+$1.96M	0.16%	97
2024 Q3	$11.8M	Buy	102,595 +33,897	+49%	+$4.65M	0.13%	144
2024 Q2	$9.46M	Buy	68,698 +44,512	+184%	+$6.1M	0.12%	158
2024 Q1	$3.34M	Buy	24,186 +11,921	+97%	+$1.63M	0.05%	289
2023 Q4	$1.62M	Sell	12,265 -5,328	-30%	-$613K	0.02%	365
2023 Q3	$1.98M	Sell	17,593 -3,088	-15%	-$325K	0.03%	351
2023 Q2	$1.95M	Buy	20,681 +16,398	+383%	+$1.6M	0.02%	376
2023 Q1	$434K	Sell	4,283 -303	-7%	-$31.5K	﹤0.01%	628
2022 Q4	$548K	Buy	4,586 +303	+7%	+$35.5K	﹤0.01%	594
2022 Q3	$455K	Buy	4,283 +307	+8%	+$31.1K	﹤0.01%	602
2022 Q2	$388K	Buy	+3,976	New	+$367K	﹤0.01%	628